Kamala Harris and Donald Trump will clash in their first Presidential debate in Philadelphia, marking a pivotal moment in a tight election race. With both candidates neck-and-neck in polls, the debate could significantly influence the outcome. This highly anticipated event follows a series of changes, including a candidate shift and an assassination attempt, creating a volatile political landscape.
Psyence Biomedical has initiated the first clinical trial site in Australia for its Phase IIb study exploring the potential of psilocybin as a treatment for Adjustment Disorder in palliative care patients. The trial, conducted in partnership with Fluence and iNGENū CRO, aims to assess the efficacy of Psyence’s naturally sourced psilocybin drug, PEX010, and could pave the way for a pivotal Phase III program.
Australian wealth management firm BT has chosen SS&C Global Investor and Distribution Solutions (GIDS) to provide unit registry services for 88 of its managed funds. This partnership will streamline operations, improve digital access for investors, and support BT’s growth ambitions in the Australian wealth management market.
A recent study published in Cannabis and Cannabinoid Research suggests that marijuana users may experience better outcomes when battling COVID-19, including lower rates of severe infection and death. The study, conducted by Northwell Health, analyzed data from the National Inpatient Sample Database and found that cannabis users had a significantly lower mortality rate and shorter hospital stays compared to non-users. While the study offers promising findings, experts emphasize the need for further research to fully understand the complex relationship between cannabis and COVID-19.
Aurora Cannabis and Vectura Fertin Pharma have partnered to launch a new CBD lozenge in Canada. This marks Vectura Fertin Pharma’s first medical cannabis CBD lozenge in the Canadian market and represents a significant step forward in their collaboration with Aurora. The lozenge, manufactured by Cogent International, a subsidiary of Vectura Fertin Pharma, offers a novel dissolvable format for easy dosing.
Hewlett Packard Enterprise (HPE) has announced a public offering of $1.35 billion in Series C mandatory convertible preferred stock. The proceeds will be used to partially fund the acquisition of Juniper Networks and for general corporate purposes. The preferred stock will automatically convert into common stock in 2027.
Robinhood Markets, Inc. (HOOD) saw its stock climb in regular trading on Monday, following the release of its August operating data. The report highlighted growth in funded customers, assets under custody, and trading volumes, despite a slight dip in some areas. Robinhood is set to present at the Goldman Sachs Communacopia + Technology Conference on Tuesday.
Calavo Growers, Inc. (CVGW) saw its stock price jump after reporting strong third-quarter financial results, exceeding analyst expectations for both earnings and revenue. The company’s avocado business continued to drive growth, while its guacamole segment also saw an increase in volume despite higher input costs.
Investors in CoStar Group (CSGP) should pay attention to the recent spike in implied volatility for its options, suggesting a potential big move in the stock price. This coincides with a mixed outlook from analysts, who have recently downgraded earnings estimates. Understanding these dynamics could be key for investors looking to capitalize on the stock’s future trajectory.
While the overall job market shows signs of weakening, executive-level hiring is experiencing a surge, driven by a wave of baby boomer retirements. This trend is impacting companies globally, leading to a rise in executive search activity and a scramble for qualified successors.
